Commentary: Efficacy and safety of low-molecular-weight collagen peptides in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial
Frontiers in Nutrition · 20.11.2025 · 12
DOI: 10.3389/fnut.2025.1712455 ↗Kurz gefasst
Kommentar in der Zeitschrift Frontiers in Nutrition, online erschienen am 20.11.2025. Verfasst von Junpeng Qiu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, China.
- The Sixth Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
Zitieren
APA
Qiu, J., Xiao, F., & Yang, J. (2025). Commentary: Efficacy and safety of low-molecular-weight collagen peptides in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1712455
Vancouver
Qiu J, Xiao F, Yang J. Commentary: Efficacy and safety of low-molecular-weight collagen peptides in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1712455
BibTeX
@article{Qiu2025,
author = {Qiu, Junpeng and Xiao, Fangjun and Yang, Junxing},
title = {Commentary: Efficacy and safety of low-molecular-weight collagen peptides in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial},
journal = {Frontiers in Nutrition},
year = {2025},
volume = {12},
doi = {10.3389/fnut.2025.1712455}
}
EUVIMED